Revision of prior period statements |
RECAST On October 17, 2022, the Company entered into an agreement with Mr. Maxim Povalishin for the sale of the Company's subsidiaries comprising the Russian segment. Because the assets and liabilities to be disposed of met the held for sale criteria, as of and for the three months ended June 30, 2022 and in the corresponding periods of 2021 and 2020 for comparative purposes. For additional information see Note 26 - Assets and Liabilities held for sale.
The previously issued Condensed Consolidated Balance Sheets as of June 30,2022 and March 31, 2022, and Condensed Consolidated Statement of Operations and Statements of Other Comprehensive Income for the three months ended June 30, 2022 and 2021, have been revised as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2022 |
|
As previously reported |
|
Recast insurance companies |
|
Recast discontinued operations |
|
As recasted |
ASSETS |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
625,547 |
|
|
$ |
816 |
|
|
$ |
(400,899) |
|
|
$ |
225,464 |
|
Restricted cash |
553,680 |
|
|
— |
|
|
(5,730) |
|
|
547,950 |
|
Trading securities |
1,203,479 |
|
|
77,395 |
|
|
(122,497) |
|
|
1,158,377 |
|
Available-for-sale securities, at fair value |
1 |
|
|
161,363 |
|
|
— |
|
|
161,364 |
|
Brokerage and other receivables, net |
357,567 |
|
|
179 |
|
|
(210,087) |
|
|
147,659 |
|
Loans issued |
94,797 |
|
|
43 |
|
|
(2,394) |
|
|
92,446 |
|
Fixed assets, net |
21,365 |
|
|
436 |
|
|
(3,978) |
|
|
17,823 |
|
Intangible assets, net |
5,791 |
|
|
1,650 |
|
|
(2,278) |
|
|
5,163 |
|
Goodwill |
5,388 |
|
|
510 |
|
|
— |
|
|
5,898 |
|
Right-of-use asset |
15,669 |
|
|
684 |
|
|
(8,922) |
|
|
7,431 |
|
Deferred tax assets |
12,018 |
|
|
51 |
|
|
(11,161) |
|
|
908 |
|
Assets from insurance activity |
— |
|
|
5,712 |
|
|
— |
|
|
5,712 |
|
Assets held for sale |
— |
|
|
— |
|
|
825,419 |
|
|
825,419 |
|
Other assets, net |
25,707 |
|
|
7,643 |
|
|
(7,214) |
|
|
26,136 |
|
TOTAL ASSETS |
$ |
2,921,009
|
|
|
$ |
256,482
|
|
|
$ |
50,259
|
|
|
$ |
3,227,750
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
Securities repurchase agreement obligations |
$ |
775,178 |
|
|
$ |
97,515 |
|
|
$ |
(32,469) |
|
|
$ |
840,224 |
|
Customer liabilities |
1,417,937 |
|
|
(983) |
|
|
(651,326) |
|
|
765,628 |
|
Trade payables |
45,229 |
|
|
1 |
|
|
(147) |
|
|
45,083 |
|
Liabilities from insurance activity |
— |
|
|
119,490 |
|
|
— |
|
|
119,490 |
|
Current income tax liability |
14,556 |
|
|
— |
|
|
— |
|
|
14,556 |
|
Securities sold, not yet purchased – at fair value |
14,103 |
|
|
— |
|
|
(238) |
|
|
13,865 |
|
Loans received |
3,538 |
|
|
— |
|
|
— |
|
|
3,538 |
|
Debt securities issued |
99,027 |
|
|
— |
|
|
(64,637) |
|
|
34,390 |
|
Lease liability |
15,315 |
|
|
719 |
|
|
(8,530) |
|
|
7,504 |
|
Deferred distribution payments |
8,534 |
|
|
— |
|
|
— |
|
|
8,534 |
|
Liabilities held for sale |
— |
|
|
— |
|
|
812,478 |
|
|
812,478 |
|
Other liabilities |
19,917 |
|
|
807 |
|
|
(4,872) |
|
|
15,852 |
|
TOTAL LIABILITIES |
2,413,334
|
|
|
217,549
|
|
|
50,259
|
|
|
2,681,142
|
|
Commitments and Contingent Liabilities (Note 25) |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding |
— |
|
|
— |
|
|
— |
|
|
— |
|
Common stock - $0.001 par value; 500,000,000 shares authorized; 59,542,212 shares issued and outstanding as of June 30, 2022, and March 31, 2022, respectively |
59 |
|
|
— |
|
|
— |
|
|
59 |
|
Additional paid in capital |
141,340 |
|
|
33,405 |
|
|
— |
|
|
174,745 |
|
Retained earnings |
426,563 |
|
|
15,361 |
|
|
— |
|
|
441,924 |
|
Accumulated other comprehensive loss |
(53,291) |
|
|
(9,834) |
|
|
— |
|
|
(63,125) |
|
TOTAL FRHC SHAREHOLDERS’ EQUITY |
514,671
|
|
|
38,932
|
|
|
—
|
|
|
553,603
|
|
|
|
|
|
|
|
|
|
Non-controlling interest |
(6,996) |
|
|
1 |
|
|
— |
|
|
(6,995) |
|
TOTAL SHAREHOLDERS’ EQUITY |
507,675
|
|
|
38,933
|
|
|
—
|
|
|
546,608
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
$ |
2,921,009
|
|
|
$ |
256,482
|
|
|
$ |
50,259
|
|
|
$ |
3,227,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2022 |
|
As previously reported* |
|
Recast discontinued operations |
|
As recasted |
ASSETS |
|
|
|
|
|
Cash and cash equivalents |
$ |
905,685 |
|
|
$ |
(659,286) |
|
|
$ |
246,399 |
|
Restricted cash |
375,118 |
|
|
48,071 |
|
|
423,189 |
|
Trading securities |
1,420,481 |
|
|
(122,079) |
|
|
1,298,402 |
|
Available-for-sale securities, at fair value |
219,470 |
|
|
— |
|
|
219,470 |
|
Brokerage and other receivables, net |
511,047 |
|
|
(278,938) |
|
|
232,109 |
|
Loans issued |
223,519 |
|
|
(11,431) |
|
|
212,088 |
|
Fixed assets, net |
29,203 |
|
|
(7,248) |
|
|
21,955 |
|
Intangible assets, net |
9,404 |
|
|
(4,028) |
|
|
5,376 |
|
Goodwill |
5,932 |
|
|
— |
|
|
5,932 |
|
Right-of-use asset |
24,394 |
|
|
(14,908) |
|
|
9,486 |
|
Deferred tax assets |
16,263 |
|
|
(14,329) |
|
|
1,934 |
|
Assets from insurance activity |
7,170 |
|
|
— |
|
|
7,170 |
|
Assets held for sale |
— |
|
|
1,168,692 |
|
|
1,168,692 |
|
Other assets, net |
49,508 |
|
|
(10,969) |
|
|
38,539 |
|
TOTAL ASSETS |
$ |
3,797,194
|
|
|
$ |
93,547
|
|
|
$ |
3,890,741
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
Securities repurchase agreement obligations |
$ |
1,030,171 |
|
|
$ |
(34,264) |
|
|
$ |
995,907 |
|
Customer liabilities |
1,652,643 |
|
|
(889,774) |
|
|
762,869 |
|
Trade payables |
82,202 |
|
|
(15,078) |
|
|
67,124 |
|
Liabilities from insurance activity |
135,563 |
|
|
— |
|
|
135,563 |
|
Current income tax liability |
23,803 |
|
|
— |
|
|
23,803 |
|
Securities sold, not yet purchased – at fair value |
7,706 |
|
|
(520) |
|
|
7,186 |
|
Loans received |
5,435 |
|
|
— |
|
|
5,435 |
|
Debt securities issued |
115,629 |
|
|
(64,636) |
|
|
50,993 |
|
Lease liability |
23,642 |
|
|
(14,098) |
|
|
9,544 |
|
Deferred distribution payments |
8,534 |
|
|
— |
|
|
8,534 |
|
Liabilities held for sale |
— |
|
|
1,119,655 |
|
|
1,119,655 |
|
Other liabilities |
79,984 |
|
|
(7,738) |
|
|
72,246 |
|
Payable for acquisition |
24,966 |
|
|
— |
|
|
24,966 |
|
TOTAL LIABILITIES |
3,190,278
|
|
|
93,547
|
|
|
3,283,825
|
|
Commitments and Contingent Liabilities (Note 25) |
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding |
— |
|
|
— |
|
|
— |
|
Common stock - $0.001 par value; 500,000,000 shares authorized; 59,542,212 shares issued and outstanding as of June 30, 2022, and March 31, 2022, respectively |
59 |
|
|
— |
|
|
59 |
|
Additional paid in capital |
152,532 |
|
|
— |
|
|
152,532 |
|
Retained earnings |
502,990 |
|
|
— |
|
|
502,990 |
|
Accumulated other comprehensive loss |
(39,676) |
|
|
— |
|
|
(39,676) |
|
TOTAL FRHC SHAREHOLDERS’ EQUITY |
615,905
|
|
|
—
|
|
|
615,905
|
|
|
|
|
|
|
|
Non-controlling interest |
(8,989) |
|
|
— |
|
|
(8,989) |
|
TOTAL SHAREHOLDERS’ EQUITY |
606,916
|
|
|
—
|
|
|
606,916
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
$ |
3,797,194
|
|
|
$ |
93,547
|
|
|
$ |
3,890,741
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2022 |
|
As previously reported* |
|
Recast discontinued operations |
|
As recasted |
Revenue: |
|
|
|
|
|
Fee and commission income |
$ |
126,727 |
|
|
$ |
(37,281) |
|
|
$ |
89,446 |
|
Net gain on trading securities |
15,582 |
|
|
(11,149) |
|
|
4,433 |
|
Net realized loss on investments available for sale |
(593) |
|
|
— |
|
|
(593) |
|
Interest income |
54,367 |
|
|
(5,804) |
|
|
48,563 |
|
Income from insurance activity |
24,241 |
|
|
— |
|
|
24,241 |
|
Net gain/(loss) on foreign exchange operations |
5,019 |
|
|
(426) |
|
|
4,593 |
|
Net gain on derivative |
1,265 |
|
|
1 |
|
|
1,266 |
|
TOTAL REVENUE, NET |
226,608
|
|
|
(54,659) |
|
|
171,949
|
|
|
|
|
|
|
|
Expense: |
|
|
|
|
|
Fee and commission expense |
25,241 |
|
|
(1,926) |
|
|
23,315 |
|
Interest expense |
45,829 |
|
|
(5,758) |
|
|
40,071 |
|
Expense from insurance activity |
16,692 |
|
|
— |
|
|
16,692 |
|
Operating expense |
65,467 |
|
|
(27,468) |
|
|
37,999 |
|
Provision for impairment losses |
2,798 |
|
|
(370) |
|
|
2,428 |
|
Other expense, net |
(527) |
|
|
(34) |
|
|
(561) |
|
TOTAL EXPENSE |
155,500
|
|
|
(35,556) |
|
|
119,944
|
|
|
|
|
|
|
|
NET INCOME BEFORE INCOME TAX |
71,108
|
|
|
(19,103) |
|
|
52,005
|
|
|
|
|
|
|
|
Income tax expense |
(12,035) |
|
|
3,156 |
|
|
(8,879) |
|
|
|
|
|
|
|
INCOME FROM CONTINUING OPERATIONS |
59,073
|
|
|
(15,947) |
|
|
43,126
|
|
|
|
|
|
|
|
Income before income tax expense of discontinued operations |
— |
|
|
19,102 |
|
|
19,102 |
|
|
|
|
|
|
|
Income tax expense of discontinued operations |
— |
|
|
(3,156) |
|
|
(3,156) |
|
|
|
|
|
|
|
Income from discontinued operations |
— |
|
|
15,946 |
|
|
15,946 |
|
|
|
|
|
|
|
NET INCOME |
59,073
|
|
|
$ |
(1) |
|
|
$ |
59,072
|
|
|
|
|
|
|
|
Less: Net loss attributable to non-controlling interest in subsidiary |
(1,994) |
|
|
— |
|
|
(1,994) |
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
$ |
61,067
|
|
|
$ |
(1) |
|
|
$ |
61,066
|
|
|
|
|
|
|
|
OTHER COMPREHENSIVE INCOME |
|
|
|
|
|
Change in unrealized gain on investments available-for-sale, net of tax effect |
866 |
|
|
— |
|
|
866 |
|
Reclassification adjustment relating to available-for-sale investments disposed of in the period, net of tax effect |
593 |
|
|
— |
|
|
593 |
|
Foreign currency translation adjustments, net of tax effect |
21,977 |
|
|
13 |
|
|
21,990 |
|
|
|
|
|
|
|
OTHER COMPREHENSIVE INCOME |
23,436
|
|
|
13
|
|
|
23,449
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME BEFORE NON-CONTROLLING INTERESTS |
$ |
82,509
|
|
|
$ |
12
|
|
|
$ |
82,521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Comprehensive loss attributable to non-controlling interest in subsidiary |
(1,994) |
|
|
— |
|
|
(1,994) |
|
|
|
|
|
|
|
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
$ |
84,503
|
|
|
$ |
12
|
|
|
$ |
84,515
|
|
|
|
|
|
|
|
For the three months ended June 30, 2022, the Company’s EPS as reported was 0.99 for both basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 0.72 for both basic and diluted EPS for continuing operations to 0.27, for both basic and diluted EPS for discontinued operations, and to 1.03 for both basic and diluted total EPS, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2021 |
|
As previously reported* |
|
Recast insurance companies |
|
Recast discontinued operations |
|
As recasted |
Revenue: |
|
|
|
|
|
|
|
Fee and commission income |
$ |
96,306 |
|
|
$ |
(24) |
|
|
$ |
(18,167) |
|
|
$ |
78,115 |
|
Net gain on trading securities |
9,900 |
|
|
841 |
|
|
(2,059) |
|
|
8,682 |
|
Net realized loss on investments available for sale |
— |
|
|
(31) |
|
|
— |
|
|
(31) |
|
Interest income |
19,178 |
|
|
6,585 |
|
|
(3,525) |
|
|
22,238 |
|
Income from insurance activity |
— |
|
|
14,076 |
|
|
— |
|
|
14,076 |
|
Net (loss)/gain on foreign exchange operations |
(1,187) |
|
|
163 |
|
|
2,232 |
|
|
1,208 |
|
Net loss on derivative |
(59) |
|
|
(1) |
|
|
1 |
|
|
(59) |
|
TOTAL REVENUE, NET |
124,138
|
|
|
21,609
|
|
|
(21,518) |
|
|
124,229
|
|
|
|
|
|
|
|
|
|
Expense: |
|
|
|
|
|
|
|
Fee and commission expense |
21,863 |
|
|
1,397 |
|
|
(2,066) |
|
|
21,194 |
|
Interest expense |
14,272 |
|
|
2,223 |
|
|
(2,249) |
|
|
14,246 |
|
Expense from insurance activity |
— |
|
|
11,296 |
|
|
— |
|
|
11,296 |
|
Operating expense |
30,318 |
|
|
2,926 |
|
|
(13,823) |
|
|
19,421 |
|
Provision for impairment losses |
293 |
|
|
— |
|
|
(26) |
|
|
267 |
|
Other expense, net |
14 |
|
|
111 |
|
|
(115) |
|
|
10 |
|
TOTAL EXPENSE |
66,760
|
|
|
17,953
|
|
|
(18,279) |
|
|
66,434
|
|
|
|
|
|
|
|
|
|
NET INCOME BEFORE INCOME TAX |
57,378
|
|
|
3,656
|
|
|
(3,239) |
|
|
57,795
|
|
|
|
|
|
|
|
|
|
Income tax expense |
(5,669) |
|
|
5 |
|
|
537 |
|
|
(5,127) |
|
|
|
|
|
|
|
|
|
INCOME FROM CONTINUING OPERATIONS |
51,709
|
|
|
3,661
|
|
|
(2,702) |
|
|
52,668
|
|
|
|
|
|
|
|
|
|
Income before income tax expense of discontinued operations |
— |
|
|
— |
|
|
3,237 |
|
|
3,237 |
|
|
|
|
|
|
|
|
|
Income tax expense of discontinued operations |
— |
|
|
— |
|
|
(537) |
|
|
(537) |
|
|
|
|
|
|
|
|
|
Income from discontinued operations |
—
|
|
|
—
|
|
|
2,700
|
|
|
2,700
|
|
|
|
|
|
|
|
|
|
NET INCOME |
51,709
|
|
|
3,661
|
|
|
(2) |
|
|
55,368
|
|
|
|
|
|
|
|
|
|
Less: Net loss attributable to non-controlling interest in subsidiary |
(52) |
|
|
— |
|
|
— |
|
|
(52) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
$ |
51,761
|
|
|
$ |
3,661
|
|
|
$ |
(2) |
|
|
$ |
55,420
|
|
|
|
|
|
|
|
|
|
OTHER COMPREHENSIVE INCOME |
|
|
|
|
|
|
|
Change in unrealized gain on investments available-for-sale, net of tax effect |
— |
|
|
874 |
|
|
— |
|
|
874 |
|
Reclassification adjustment relating to available-for-sale investments disposed of in the period, net of tax effect |
— |
|
|
31 |
|
|
— |
|
|
31 |
|
Foreign currency translation adjustments, net of tax effect |
3,300 |
|
|
(278) |
|
|
— |
|
|
3,022 |
|
|
|
|
|
|
|
|
|
OTHER COMPREHENSIVE INCOME |
3,300
|
|
|
627
|
|
|
—
|
|
|
3,927
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME BEFORE NON-CONTROLLING INTERESTS |
$ |
55,009
|
|
|
$ |
4,288
|
|
|
$ |
(2) |
|
|
$ |
59,295
|
|
|
|
|
|
|
|
|
|
Less: Comprehensive loss attributable to non-controlling interest in subsidiary |
(52) |
|
|
— |
|
|
— |
|
|
(52) |
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS |
$ |
55,061
|
|
|
$ |
4,288
|
|
|
$ |
(2) |
|
|
$ |
59,347
|
|
|
|
|
|
|
|
|
|
For the three months ended June 30, 2021, the Company’s EPS as reported was 0.87 for both basic and diluted EPS. Due to the items noted above, the Company’s EPS has been recast to 0.89 and 0.88 for both basic and diluted EPS respectively for continuing operations, to 0.05 for both basic and diluted EPS for discontinued operations, and to 0.93 for both basic and diluted total EPS, respectively.
*amounts with restatement in fee and commission income and interest income, for more information please see Note 4 Restatement.
|